A case with psoriasis-like lesions induced by olmutinib (HM61713) while treating epidermal growth factor receptor T790M mutant advanced lung adenocarcinoma

Olmutinib (HM61713) is a third-generation tyrosine kinase inhibitor active against mutant EGFR, including T790M in nonsmall cell lung cancer. The most common side effect of olmutinib to date includes diarrhea, rash, nausea, and pruritus. To the best of our knowledge, it is the first case of psoriasi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chu-Ju Hung (Author), Po-Ju Lai (Author), Jen-Jung Cheng (Author), Shiow-Jiuan Wey (Author), Yu-Ping Hsiao (Author), Ming-Fang Wu (Author)
Formato: Livro
Publicado em: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível